Cannabinoids and Neuropsychiatric Disorders

de

, ,

Éditeur :

Springer


Paru le : 2020-12-17

eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
147,69

Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues.

Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (?9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial.
The themes of this book have been edited and  written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy.
Pages
153 pages
Collection
n.c
Parution
2020-12-17
Marque
Springer
EAN papier
9783030573683
EAN PDF
9783030573690

Informations sur l'ebook
Nombre pages copiables
1
Nombre pages imprimables
15
Taille du fichier
5151 Ko
Prix
147,69 €
EAN EPUB
9783030573690

Informations sur l'ebook
Nombre pages copiables
1
Nombre pages imprimables
15
Taille du fichier
3502 Ko
Prix
147,69 €

Suggestions personnalisées